Diabetes distress is the negative emotional impact of living with diabetes. It has tangible clinical importance, being associated with sub-optimal self-care and glycemic control. Diabetes distress has been operationalized in various ways and several measures exist. Measurement clarity is needed for both scientific and clinical reasons.
Introduction
Living with diabetes is complex and involves various self-care activities, e.g. medication taking, healthy eating, carbohydrate counting, physical activity, checking blood glucose, and problem solving (Peeples et al., 2007) . These self-care behaviors are required to keep glycated hemoglobin (HbA1c) in target range, to prevent/delay onset of devastating complications (American Diabetes Association, 2003) . The burden of self-management, living with diabetes-related complications (or the risk of their development), and managing difficult social situations, have the potential to cause considerable emotional distress. In the mid-1990s, the emotional impact of living with diabetes was brought to the fore, with introduction of the concept of 'diabetes distress' (DD) (Polonsky et al., 1995) . DD emerged from research on stress and coping, and emotional regulation in response to specific acute or chronic stressors, which suggests that emotions can emerge from specific situational contexts and that emotional distress is a response to perceptions of health threats balanced against an appraisal of available coping resources (Fisher, Gonzalez, & Polonsky, 2014) .
In recent years, research into DD has gained significant traction. Around one quarter of UK adults with diabetes experience elevated, or severe, DD at any given time (Dennick et al., 2016; Sturt, Dennick, Due-Christensen, & McCarthy, 2015) . Similar rates are reported elsewhere in Europe (Stoop et al., 2014) , Australia (Speight et al., 2011) and the USA (Fisher, Skaff, et al., 2008) . Almost 50% of people experience elevated DD over an 18-month period (Fisher, Skaff, et al., 2008) . It should be noted, though not the focus of this review, that DD is additionally well-documented among partners of those with diabetes (Polonsky, Fisher, Hessler, & Johnson, 2016) , children and adolescents with diabetes (Hagger, Hendrieckx, Sturt, Skinner, & Speight, 2016) and parents of children and adolescents with diabetes (Johnson, 2013) . Indeed, measures of DD specific to the needs of these populations have been developed (Markowitz et al., 2012; Polonsky et al., 2016; Weissberg-Benchell & Antisdel-Lomaglio, 2011) .
DD is positively associated with HbA1c, such that fluctuations in each correspond over time (Aikens, 2012; Fisher et al., 2010; Fisher et al., 2007; Schmitt, Reimer, Kulzer, Haak, Gahr, et al., 2015) , and reductions in DD are accompanied by clinically significant improvements in HbA1c (Strandberg, Graue, Wentzel-Larsen, Peyrot, & Rokne, 2014; Zagarins, Allen, Garb, & Welch, 2012) . DD also impacts upon certain self-management behaviors (Aikens, 2012; Fisher et al., 2007) . These relationships have primarily been associative, however, and hence do not indicate causality. Individuals with high DD are less likely to participate in educational and self-management interventions (Fonda, McMahon, Gomes, Hickson, & Conlin, 2009) , and exhibit less improvement in HbA1c following such interventions (Weinger & Jacobson, 2001) . Conversely, when interventions target DD, individuals with elevated DD engage to a greater extent and this results in improved DD, self-management and HbA1c . This emerging evidence has prompted calls for further interventions to target DD (Fisher et al., 2007) .
From a clinical perspective, measurement clarity is crucial to ensure appropriate identification of need and tailoring of care. From a scientific perspective, it is necessary to ensure valid operationalization of constructs, maximum responsiveness of measures to enable demonstration of effective interventions, and appropriate interpretation of data (U.S. Department of Health and Human Services, 2009). US and European regulatory bodies have released guidance on the development and use of patient-reported outcome measures (PROMs), describing the scientific rigor with which such measures must be developed to enable meaningful measurement and outcomes evaluation (European Medicines Agency Committee for Medicinal Products for Human Use, 2005; U.S. Department of Health and Human Services, 2009). First among the issues discussed is content validity, i.e. the extent to which a questionnaire measures what is claimed. A 'conceptual model' provides a representation of the relevant concepts that comprise the construct, and the relationships among the concepts. It should be developed, following a systematic literature review and qualitative work with patients and health professionals, to inform the structure and content (items) of a new questionnaire.
In the academic literature, the concept of DD has been assumed to be relatively simple. However, definition and measurement have been circular. DD is defined largely with reference to the issues measured by the Problem Areas in Diabetes (PAID) scale (Polonsky et al., 1995) , which is widely regarded as the first PROM to assess DD in adults. Thus, the PAID is widely considered a suitable measure of DD. The more recently developed Diabetes Distress Scale (DDS) (Polonsky et al., 2005) is also gaining traction as a measure of DD in adults. Recent research has suggested that there are important content differences between the PAID and the DDS (Schmitt, Reimer, Kulzer, Haak, Ehrmann, et al., 2015) . Until the emergence of the DDS, there had been little discussion about what comprises DD or of the rationale for questionnaire selection. Indeed, it is unclear whether other questionnaires might also be suitable for assessing DD.
Furthermore, while many clinicians/researchers refer to the PAID and DDS (seemingly) appropriately as measures of DD, others have used broader terminology, such as (diabetes-specific) quality of life (Tang, Brown, Funnell, & Anderson, 2008) and diabetes-dependent impairment (Kempf & Martin, 2013) . Similarly, measures assessing other constructs (e.g. the ATT-39, which assesses diabetes attitudes and beliefs) have been reported as measures of DD (Esbitt, Tanenbaum, & Gonzalez, 2013; Snoek, Bremmer, & Hermanns, 2015) . Beyond operationalizing DD with the PAID or the DDS, a common understanding of how to conceptualize DD and differentiate it from other commonly assessed constructs has not yet emerged in the literature. Previous reviews have disentangled the conceptualization and measurement of other diabetesspecific PROMs (Garratt, Schmidt, & Fitzpatrick, 2002; Polonsky, 2000; Speight, Reaney, & Barnard, 2009) . Recently, researchers have also sought to clarify the conceptual distinction between DD and depression (Fisher, Gonzalez, et al., 2014; Fisher et al., 2010; Fisher et al., 2007; Snoek et al., 2015) . To date there has been no attempt to derive a conceptual model of DD, identify and distinguish measures of DD from the vast array of other diabetes-specific PROMs, and explore their validity for this purpose.
Thus, our overall aims were to: a) conceptualize and operationalize DD; b) identify measures of the broad concept of DD by examining their face validity in terms of measuring DD (i.e. the extent to which a measure looks as though it measures DD); and c) review the content validity of the identified measures in terms of assessing DD (i.e. the aspects of DD covered and the extent to which it is likely that each measure captures DD comprehensively) with a view to offering guidance on the context-specific selection of measures.
Materials and methods
We began by considering existing definitions of DD in order to derive a common understanding of its conceptualization and operationalization. Several definitions (Aikens, 2012; Esbitt et al., 2013; Fisher, Gonzalez, et al., 2014; Polonsky, 2000; Polonsky et al., 1995; Schmitt, Reimer, Kulzer, Haak, Gahr, et al., 2015; Welch, Jacobson, & Polonsky, 1997) have been applied over the past 20 years, ranging from a brief early description (e.g. "Breadth of emotional responses to diabetes" (p755) (Polonsky et al., 1995) to more recent detailed explanations (e.g. "Significant negative psychological reactions that are specific to one's diabetes diagnosis, potential or actual complications, selfmanagement burdens, difficult patient-provider relationships, and problematic interpersonal relationships" (p2472) (Aikens, 2012) . In summary, DD is characterized as a range of negative emotional responses (e.g. worry, fear, frustration, guilt, sadness, anger, overwhelm), to aspects of M A N U S C R I P T
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Distinguishing measures of diabetes distress 5 living with and managing diabetes balanced against an appraisal of available coping resources. Living with and managing diabetes comprises many aspects (e.g. self-care, problem-solving, interpersonal relationships), each of which may be associated with a certain amount of emotional distress that can vary over time within and between individuals/sub-groups of people with diabetes. For example, sources and severity of distress can differ between those with type 1 and type 2 diabetes, and those managing type 2 diabetes with different treatment regimens (Baek, Tanenbaum, & Gonzalez, 2014; Tanenbaum, Kane, Kenowitz, & Gonzalez, 2016) . These definitions offer insights into the conceptualization of DD and hence inform its operationalization. However, many are vague, and none is fully comprehensive. Collectively, they suggest that measures of DD need to focus on the emotional distress associated with everyday aspects of living with diabetes.
The literature is replete with conceptual overlap between DD and diabetes-specific quality of life. We conceptualize the latter as the extent to which aspects of life (e.g. working life, family life, social life, finances, etc.) contributing to overall quality of life may be impaired by living with and managing diabetes. Diabetes can have a negative impact on quality of life without causing severe emotional distress, though the reverse is less likely to be true. Thus, measures of diabetes-specific quality of life elicit a cognitive response (considered thoughts) about the extent of the impact of diabetes on important aspects of life. This is contrast to DD, which is the emotional response to specific aspects of living with and managing diabetes.
Identification and selection of measures
We considered all diabetes-specific PROMs (suitable for completion by adults) eliciting the personal impact of diabetes, hence excluding measures that were evidently not focused on DD (e.g. diabetes knowledge and self-care). We identified the measures while conducting a published systematic review (Dennick et al., 2016; Sturt, Dennick, Hessler, et al., 2015) and by hand-searching published reviews of diabetes-specific PROMs (Eigenmann, Colagiuri, Skinner, & Trevena, 2009; El Achhab, Nejjari, Chikri, & Lyoussi, 2008; Hirsch, Bartholomae, & Volmer, 2000; Luscombe, 2000; Watkins & Connell, 2004) . Any additional measures of potential relevance known to the authors were also included. Copies of the questionnaire and development work were obtained (e.g. from published papers, the internet, or direct from authors). We included measures with published psychometric properties and at least one citation of the development work in the previous year (Web of Science, December 2014), and abstracts published within the past three years (but with no citations) considered to be potentially 'emerging' measures. We considered only the full version of each measure, rather than short-form instruments. Where measures had been revised or English language papers had subsequently been published, these revised measures, and the associated development papers, were considered.
Assessment of face validity
Measures were assessed independently by two authors (KD/JSt) in terms of their face validity as a measure of DD (i.e. regardless of existing descriptions of their purpose by the scale developers or other authors). Decisions were verified, disagreements resolved, and consensus achieved through discussion with a third author (JSp). We applied the following criteria when considering the content of full measures and their constituent, validated sub-scales:
1. Do the items relate to aspects of living with and managing diabetes (i.e. offering reasonable certainty that the person's response relates to their diabetes)? For example, measures excluded would refer to aspects of life, activities of daily living, or social support rather than to diabetes, or have limited scope, focusing on an aspect of diabetes not necessarily specific to this, e.g. diet, exercise, anxiety or depression. 2. Do the items elicit the emotional distress in relation to the above via their item wording? Or, do the completion instructions (or response options) prompt respondents to focus on M A N U S C R I P T
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Distinguishing measures of diabetes distress 6 emotional distress? For example, measures excluded would refer to how people think about diabetes and its impact upon their lives rather than to how they feel about their diabetes.
Where some but not all items were considered to assess DD, we determined that, for a measure to assess DD, at least 75% of the items would need to assess the emotional distress associated with diabetes.
Review of content validity
We explored content validity for assessing DD by contrasting the focus and scope of the identified measures in terms of the aspects of DD included and the detail associated with each respectively. Figure 1 illustrates the selection process in a flow diagram. Fifty-three diabetes-specific PROMs for adults were identified, of which 37 had evidence of psychometric validation. Twenty-nine of these were measures of the personal impact of diabetes, of which 19 met our citation criteria and could be obtained. Citations, and the results from the citation search, for the excluded measures are available (online Appendix). The 19 short-listed measures assessed comprise 91 single-factor scales or subscales, of which 62 assess the personal impact of diabetes.
Results

Identification and selection of measures
*FIGURE 1* 
Face validity 3.2.1 Measures of DD
Measures that capture elements of DD but with limited scope
Eight scales/sub-scales were considered to capture elements of DD but be too limited in scope (Table 1) . For example, the Hypoglycemia Fear Survey II (HFS-II) 'Worry' sub-scale (Cox, Irvine, Gonder-Frederick, Nowacek, & Butterfield, 1987) requires respondents to indicate how much they have worried about each issue (item) because of low blood glucose. The content is relevant to DD but highly focused on a specific aspect of living with diabetes (i.e. hypoglycemia). Similarly the Inhaled Insulin Treatment Questionnaire (IITQ) 'Diabetes Worries' sub-scale (Rubin & Peyrot, 2010) captures only worry related to hypo-and hyperglycemia and long-term complications. Some Diabetes Symptom Checklist-Revised (DSC-R) sub-scales (Arbuckle et al., 2009; Grootenhuis, Snoek, Heine, & Bouter, 1994) capture the emotional distress associated with diabetes symptoms. The emotional distress associated with other aspects of living with and managing diabetes is missing from these measures, thus they are too limited in scope to be considered measures of DD. (Bradley et al., 1999) ; Appraisal of Diabetes Scale (ADS): 'How much is your quality of life affected by the food restrictions required to control your diabetes?' (Boyer & Earp, 1997) . Some of these measures also comprise items that tap closely related but distinct constructs, for example self-efficacy and coping ( Figure 1 ). The Questionnaire on Stress in Patients with Diabetes (QSD-R) (Duran, Herschbach, Waadt, Strian, & Zettler, 1995; Herschbach et al., 1997) is constructed such that the completion instructions/response options, and/or the item wording (e.g. 'at times I can't help worrying that I will develop complications later in life'), elicit emotional distress. However, many items do not enquire specifically about diabetes (e.g. 'I suffer from wind') or are cognitively framed, i.e. asking what people think rather than how they feel. It is likely to be more appropriate to consider such measures as assessing the related concept of diabetes-specific quality of life than DD.
Measures that do not assess DD
Content validity
There was considerable variability in the operationalization of DD and therefore the focus and scope of the identified measures. Table 3 illustrates the aspects of DD included in each measure. Items were tabulated into categories based on distinct aspects of living with and managing diabetes, initially borne out of consideration of the empirically established DDS sub-scales (Polonsky et al., 2005) . Sub-categories were then distinguished using a bottom up approach. We mapped items onto the broad construct of DD where we considered that it had the best fit, so any mismatch is our own and not necessarily that intended by the questionnaire developers. The shading indicates that two or more measures capture that particular aspect of DD, with the corresponding items appearing adjacently. Various aspects of DD are covered across the measures, yet there is considerable variability between them. No measure is fully inclusive; each one evidences omissions relative to the others. The measures are also variable in their coverage of some of the aspects of DD that are included; some operationalize an issue with a single item whereas others use several.
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Treatment regimen
The PAID, DDS, and the T1-DDS, each capture the distress associated with feeling guilty and a failure, and unmotivated and despondent, in relation to the treatment regimen. The DDS is more comprehensive than the PAID and the T1-DDS is particularly thorough in this endeavor. The TI-DDS, and the W-BQ 28 and DSQoLs-R sub-scales, capture treatment burden-related distress and the DSQoLs-R sub-scale has a narrow focus specifically on this. Indeed, treatment-regimen distress is frequently endorsed as a serious problem by diabetes research participants, especially those using insulin (Delahanty et al., 2007; Fisher, Polonsky, et al., 2014; Tanenbaum et al., 2016) , and research has shown that it may have the largest and most uniform effect upon diabetes outcomes relative to other aspects of DD, especially in type 1 diabetes (Polonsky et al., 2005; Strandberg et al., 2014) . Developed specifically for people with type 1 diabetes, it is unsurprising that the T1-DDS and the DSQoLs-R sub-scale focus on these aspects of DD. The DSQoLs-R was also not originally conceived as a measure of DD, which would explain its limited scope.
Food/eating
Emotional distress surrounding food and eating also ranks high amongst concerns for people with diabetes (Delahanty et al., 2007; Kokoszka et al., 2009; Tanenbaum et al., 2016) . The PAID, DDS, T1-DDS and DSQoLs-R sub-scale offer variable coverage of this, with the PAID and T1-DDS being most inclusive, whilst the W-BQ28 omits this.
Hypoglycemia
The T1-DDS, and to a lesser extent the PAID, uniquely elicit distress associated with hypoglycemia, despite the fact that fear of hypoglycemia is well recognized as a distressing aspect of diabetes (Delahanty et al., 2007; Kokoszka et al., 2009; Tanenbaum et al., 2016) and has been demonstrated to have a major impact on diabetes outcomes (Wild et al., 2007) . Early measures may offer limited coverage of this element of DD because they were not developed specifically for insulin-treated diabetes and the use of insulin as a treatment option for type 2 diabetes has emerged in more recent years.
Future/complications
Worry about the future and the threat of complications has also been shown consistently, across many studies, to be a frequently endorsed concern amongst people with diabetes (Delahanty et al., 2007; Kokoszka et al., 2009; Tanenbaum et al., 2016) . Most of the measures, except the DSQoLs-R and IPQ-R sub-scales, elicit distress associated with concern about complications and/or the future, albeit only the PAID additionally captures distress associated with existing complications. That said, across these measures there is typically greater attention to daily treatment burden than distress associated with complications. There is evidence, however, that people not using insulin to manage their diabetes worry more about co-morbid medical conditions than more immediate issues, such as daily treatment burden (Tanenbaum et al., 2016) .
Negative emotional experiences related to diabetes
Both the PAID and DDS offer coverage of the aspects of DD resulting from negative emotional experiences of living with diabetes, rather than practical or behavioral aspects of diabetes, such as monitoring blood glucose, albeit the PAID does so more comprehensively. These PAID items evidence the greatest association with depressive symptoms (Kokoszka et al., 2009) and it is the comorbidity of DD and low mood that seems to have the greatest impact upon HbA1c (Schmitt, Reimer, Kulzer, Haak, Gahr, et al., 2015) . The T1-DDS and the DSQoLs-R sub-scale largely or entirely omit this aspect of DD. It may be that treatment burden supersedes the negative emotional experiences of living with type I diabetes. The W-BQ 28 sub-scale predominantly taps this element of DD with a focus on negative affect and acceptance, and the IPQ-R exclusively captures this. This is
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Distinguishing measures of diabetes distress unsurprising given these are primarily measures of emotional well-being, with the W-BQ 28 enquiring about diabetes generally (rather than specific aspects of managing diabetes) and the IPQ-R sub-scale eliciting aspects of distress resulting from negative emotional experiences that are applicable across illnesses.
Social/interpersonal
Both the W-BQ 28 and DSQoLs-R sub-scales omit distress associated with interpersonal issues and social support, whilst the other measures offer variable coverage of this issue. A body of evidence indicates that positive and negative social support behaviors have significant implications for selfmanagement (Tang et al., 2008) , for instance spousal disregard for the treatment regimen and tempting with so-called 'forbidden' foods (Henry, Rook, Stephens, & Franks, 2013) . The T1-DDS also uniquely elicits distress associated with an additional aspect of interpersonal DD not included in the other scales; fear of discrimination in relation to employment.
Health care professionals
The DDS and T1-DDS, and to a lesser extent the PAID, elicit distress associated with health care professional interactions, while the sub-scales do not capture this issue at all. People with diabetes report that the support (or lack of support) -informational, instrumental, emotional -from health care professionals is pivotal to emotional well-being and expertise in self-management (Balfe et al., 2013; Furler et al., 2008; Thorne & Paterson, 2001) . The PAID items were initially developed via patient interviews but also in consultation with health care professionals; perhaps provider-related distress was less likely to be elicited. Indeed, health care professionals cannot be presumed to understand every aspect of DD as people with diabetes would experience it.
Discussion
We identified three full measures and three sub-scales assessing DD. A number of other measures capture a very narrow aspect of this construct (e.g. hypoglycemia-related distress), and many other measures elicit a cognitive reflection on, rather than emotional reaction to, diabetes (i.e. items elicit how they think rather than how they feel about diabetes).
The identified measures capture many aspects of DD as a whole, yet there is marked variability between them in terms of their focus and scope. None is fully inclusive. It has been reported previously that the PAID covers a greater variety of emotional concerns, and has a stronger focus on distress associated with food and eating, existing complications, and hypoglycemia, while the DDS focuses on health care professional and treatment regimen distress (Schmitt, Reimer, Kulzer, Haak, Ehrmann, et al., 2015) . This finding is somewhat unsurprising given distinctions in the developer's goals, and some of the relative omissions may reflect imbalance in the populations from which the items were derived in accordance with these aims. For example, numerous aspects of DD that are unique to type 1 diabetes have recently been identified (Balfe et al., 2013; Fisher et al., 2015) and this formed the basis for developing the T1-DDS (Fisher et al., 2015) . They may also reflect distinctions in methodological approach; the DDS items reflect four domains considered central to diabetes-related emotional distress created a priori based on focus groups discussions whereas the PAID was not apparently informed by any such structure when it was developed 10 years earlier. 
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Distinguishing measures of diabetes distress 10 2013; Tanenbaum et al., 2016) , it does not appear that any single existing measure of DD meets required standards for assuring content validity or offers a fully comprehensive measure of DD.
Limitations of identified measures
In terms of the six measures that we identified, some important caveats are noteworthy. These measures are variable in the extent to which they provide a direct measure of the nature or amount of emotional distress experienced in relation to a stressor and instead elicit an appraisal of a stressor (and the extent to which this bothers them). Exemplar items from the DDS are 'Feeling overwhelmed with the demands of living with diabetes' and 'Feeling that I am not testing my blood sugars frequently enough' respectively. This issue may partly explain inconsistency in studies that have attempted to empirically distinguish DD and depressive symptoms (Gonzalez, Fisher, & Polonsky, 2011) .
Such nuances in item wording may also introduce content overlap with measures of other constructs. For example, the DDS item 'Feeling that I am not testing my blood sugars frequently enough' captures feelings of guilt and self-blame etc. associated with blood glucose testing but also success in executing self-management behaviors. This may explain inconsistency in associations between DD and self-management behaviors (Aikens, 2012; Gonzalez, Delahanty, Safren, Meigs, & Grant, 2008) . Indeed some recent studies have restricted analyses of the association between diabetes distress and self-management to the emotional-burden sub-scale of the DDS to avoid contamination (Gonzalez, Shreck, Psaros, & Safren, 2015) .
Strengths and limitations of the research
We applied a rigorous and systematic approach to identifying measures of DD, some of which have not previously been considered for this purpose, distinguishing these from other measures that may, mistakenly, be considered to measure DD. We have also brought to the fore that existing This review is not without limitations, though. This was not a systematic review, albeit the measures identified were derived from a systematic search for studies that measured DD during which over 16,000 references were screened (Dennick et al., 2016; Sturt, Dennick, Hessler, et al., 2015) . Moreover, we applied an arbitrary threshold (at least 75% items focusing on DD) for a measure to be considered to assess DD. In the absence of any convention, we considered this a reasonable threshold to indicate a focus on DD. There was a tangible distinction between measures that met this criterion and those that did not. We were unable to obtain the completion instructions and/or scoring key for some measures, hence they could not be considered in their entirety (i.e. Well-being Enquiry for Diabetes (WED) (Mannucci, Ricca, Bardini, & Rotella, 1996) and Diabetes 39 (D39) (Carey et al., 1991) . It is unlikely, however, that this information would alter the conclusion that these are not appropriate measures of DD. Finally, we did not assess the utility of published short forms such as the PAID-5 (McGuire et al., 2010) and DDS-2 (Fisher, Glasgow, Mullan, Skaff, & Polonsky, 2008) . As the field moves forward, it is likely that these measures will become more widely used as screening tools and these questions may require revision.
Future directions
In the absence of detailed information about the development work underpinning the identified measures, and qualitative work suggesting omissions, supplementary work may be required to revise a measure, or measures, of DD that achieve content validity for their specific objective, and indeed publications that report on this, are warranted. Such endeavors need to be mindful of item wording, such that a direct assessment of the emotional distress experienced is attained and M A N U S C R I P T
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Distinguishing measures of diabetes distress 11 content overlap with measures of other constructs is avoided. The work that has recently been undertaken in devising a measure specific to the unique issues experienced by people with type 1 diabetes should perhaps be mirrored specifically in type 2 diabetes with attention to recent evidence reporting on qualitative distinctions in the source of DD according to treatment regimen (e.g. insulin versus oral therapies) (Tanenbaum et al., 2016) . The development work underpinning the PAID and DDS did not distinguish between different types of diabetes, and recent evidence suggests type-specific measures are warranted (Fenwick et al., 2016) . The main purpose of measures of DD is likely to remain to evaluate service delivery, medications, education or other interventions. Hence, further work is required to ensure that scientific measurement of DD meets international standards for use in clinical trials.
Implications of the findings
In terms of currently available measures, we anticipate that this review will enable clinicians and researchers to better identify the most appropriate measure for their purpose. When selecting a measure of DD, it is pertinent to ask the following questions:  What is my population: Type 1 or Type 2 diabetes?  What is my purpose in measuring DD; is my intention to capture a greater breath of the construct or is a shorter measure assessing a single, more focused construct sufficient/appropriate?  (For observational studies and clinical audits): Which aspects of DD do I want to measure/quantify?  (For experimental studies and interventional care pathways): What aspect of DD am I targeting/do I anticipate will be influenced by the intervention?
Once these parameters have been established, Table 3 can be used to guide selection of DD measures. For example, for an intervention targeting treatment-regimen distress in adults with type 1 diabetes, the T1-DDS would likely maximize responsiveness in outcome measurement. It should also be noted that readers may wish to consider using (any combination of) psychometricallyvalidated sub-scales of the DDS, T1-DDS and W-BQ28, when these more narrowly defined elements of DD better suit the intended purpose. Similarly, readers may also wish to consider the additional eight scales/sub-scales considered to capture specific elements of DD but excluded from this review due to their limited scope (see Table 1 ).
Conclusions
We have presented a conceptualization and operationalization of DD, isolated six appropriate measures of DD, distinguished them from other related measures, and offered guidance on their context-specific selection. Further research may be required to optimize the content validity of the measures identified in terms of assessing DD to meet international standards for use in clinical trials. Across the available measures, though, DD is seemingly comprehensively assessed and measures should be considered in terms of their focus and scope to ensure that the foci of interventions are appropriately targeted.
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Yes
Yes -all sub-scales ≥75% items DD (i.e. 'Diabetesspecific Negative Well-being', 'Diabetes-specific Positive Well-being' & 'Diabetes-specific Stress')
DSQoLs-R: Diabetes-specific Quality of life Scale-Revised (Burdens and
Restrictions sub-scale) (Bott et al., 1998; Cooke et al., 2013) ADDQoL: Audit of Diabetes-Dependent Quality of Life (Bradley et al., 1999) No No sub-scales ADS: Appraisal of Diabetes Scale (Carey et al., 1991) 
No
No sub-scales N/A: The full measure was not assessed rather one or more sub-scales were excluded because they did not assess the personal impact of diabetes. Citations in bold distinguish the version of the measure and development paper that was considered.
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Distinguishing measures of diabetes distress 22 Items generated with 10 HCPs (including diabetes nurse specialists, dieticians and diabetologists) and during routine patient interviews (focusing on difficulties experienced in living with diabetes). Piloted on 25 insulin requiring female patients (predominantly T1D), with item revisions (Polonsky et al., 1995) .
Internal reliability (α=.95) and convergent (HbA1c, general distress, psycho-social functioning, fear of hypoglycemia and disordered eating) and known groups (diabetes type) validity established in a sample of insulin requiring female patients (n=451) (Polonsky et al., 1995) .
DDS: Diabetes Distress Scale
citations (2014)
'Emotional Burden' (3), 'Physicianrelated Distress' (4), 'Regimenrelated Distress' (5), 'Interpersonal Distress' (3)
'Consider the degree to which each of the items may have distressed or bothered you during the past month' (plus prompted to indicate how much they are bothered by each item not whether it is merely true and preamble -life with diabetes can be tough and result in many problems and hassles that vary in severity and the items reflect problem areas that people with diabetes may experience) Items generated by people with diabetes & HCPs (including diabetes nurse specialists, dieticians, diabetologists and diabetesknowledgeable psychologists), based on a priori domains of diabetes distress and review of PAID, QSD-R and ATT39 items (new & similar items suggested). Piloted on several small groups of patients (not described), with item revisions (Polonsky et al., 2005) .
Internal reliability (α=.93) and convergent (depressive symptoms, self-care behaviour, cholesterol) and known groups (regimen type) validity were established at the full measure and sub-scale level in diverse multisite samples of patients with Type 1 and T2D participating in larger trial and observational studies (n=683) (Polonsky et al., 2005) . M A N U S C R I P T Extended version of the W-BQ12: new stress and diabetes-specific wellbeing/stress items were generated, but method not reported (development work published in conference abstract only [28] ). Piloted on N=789 diabetes outpatients in DIABQoL+ study, with item revisions (Speight & Bradley, 2002) .
ACCEPTED MANUSCRIPT
Preliminary psychometric validation suggested internal reliability (at the sub-scale level α=.80-.87), test-retest reliability (.79), convergent validity (HbA1c) and sensitivity to change [28] . Internal reliability (α=.84-.90), convergent (correlations between W-BQ28 sub-scales), divergent (treatment satisfaction and self-care) and known-groups (age, gender and HbA1c) validity were subsequently confirmed at the full-scale and subscale level and published in a sample of people with T2D (n=353) (Speight et al., 2012) . M A N U S C R I P T Underwent a substantial revision resulting in omissions, modifications and addition of items such that the burdens and restrictions sub-scales comprise an additional 13 items, yet the validation work underpinning this has not been published. An English language version was subsequently developed (Cooke et al., 2013) .
English language version demonstrated internal reliability (α=.85-.94), concurrent validity (D-SQoL), discriminant validity (depressed mood, generic QoL, and life satisfaction) and known-groups validity (presence of diabetes-related complications) at the full-scale and sub-scale level in T1D using baseline data across three UK DAFNE study sites (Cooke et al., 2013) . Quantitative assessment of the 5 dimensions of cognitive representations of illness (Leventhal's Self-Regulatory Model); identity, consequences, timeline, control/cure and cause (items derived theoretically to assess these dimensions, by the authors and via patient interviews). Subsequently revised to improve measurement properties and extend scope; new items added, existing structure altered, and two subscales added; 'illness coherence' and 'emotional representations' (a previously overlooked component of Leventhal's model; items tap 6 affective responses to illness proven to be sensitive to differences in illness perceptions and predict health behaviors) (Moss-Morris et al., 2002) .
IPQ-R:
IPQ-R was then validated in 8 UK patient groups including diabetes. Internal reliability (α=.79-.89) and predictive, known-groups and discriminant validity were established for full measure and sub-scales; only the latter was established in diabetes (i.e. a discriminant association with general affective disposition) (Moss-Morris et al., 2002) . †At the time that the citation search was undertaken only a conference paper, published within the previous three years, was available reporting on the development of the T1-DDS hence this was included as a potentially emerging measure. A C C E P T E D M A N U S C R I P T A C C E P T E D M A N U S C R I P T A C C E P T E D M A N U S C R I P T A C C E P T E D M A N U S C R I P T Feeling that I can't ever be safe from the possibility of a hypoglycemic event (#27)
A C C E P T E D M A N U S C R I P T
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T Feeling that my family and friends make a bigger deal out of diabetes than they should (#6)
Feeling that my friends of family act like "diabetes police" (bother me too much)
Feeling that friends and family do not understand
Feeling that friends of family don't appreciate how difficult living with diabetes can be (#13)
A C C E P T E D M A N U S C R I P T A C C E P T E D M A N U S C R I P T 
